NRS 629.380
Compounding of drug, medicine or health product using nonembryonic cells authorized.

629.300
Definitions. 629.310
“Allogeneic” defined. 629.320
“Autologous” defined. 629.330
“Nonembryonic cells” defined. 629.340
Scope of regulation, disciplinary action, liabilities or penalties for engaging in authorized activities. 629.350
Provisions do not indicate status of authorized activities under federal law. 629.360
Operation of cell or tissue bank authorized. 629.370
Administration of nonembryonic cells. 629.380
Compounding of drug, medicine or health product using nonembryonic cells authorized. 629.390
Importation and administration of certain compounds, drugs or treatments containing nonembryonic cells authorized.